AL-LAD
Chemistry
- Formula
- C22H27N3O
- Molar mass
- 349.5 g/mol
- IUPAC name
- (6aR,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- InChIKey
- JCQLEPDZFXGHHQ-OXQOHEQNSA-N
Chemistry from PubChem CID 15227511.
Also known as
- 65527-61-9
- 6-allyl-6-nor-LSD
- 020O2SR91L
- DTXSID30215822
- RefChem:1084202
- DTXCID60138313
- Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-(2-propen-1-yl)-, (8beta)-
- N-Allylnorlysergic Acid N,N-Diethylamide
Stereoisomers
3 distinct stereoisomers are registered for this structure.
- Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-(2-propen-1-yl)-, (8beta)- this area CID 15227511
- N-Allylnoriso-LSD CID 15227512
- (6aS,9R)-N,N-diethyl-7-prop-2-enyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide CID 172203296
- 6-Nor-allyl-lysergic acid diethylamide mixture CID 1872
Attribution
The N(6)-allyl analogue of LSD. Reported by Andrew J. Hoffman and Nichols at Purdue; substituted for LSD in rats at roughly 2–3x LSD's potency.
General Open discussion — anything that fits nowhere narrower. no posts yet Legal Scheduling status, pending actions, and where the law actually stands. no posts yet Dosage Dose ranges by route, and the margins between them. no posts yet Experiences First-hand reports — set, setting, and what actually happened. no posts yet Chemistry Structure, synthesis, and analytical chemistry. no posts yet Interactions Combination risks — what must not be mixed, and why. no posts yet
No posts here yet.